|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Retinitis Pigmentosa | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Retinitis | |||||
| 3 | More general conditions related to this trial | ||||
| Eye Diseases | |||||
| Eye Diseases, Hereditary | |||||
| Genetic Diseases, Inborn | |||||
| Retinal Degeneration | |||||
| Retinal Diseases | |||||
| 4 | Interventions listed in this trial | ||||
| Argus II Retinal Stimulation System | |||||
| 5 | Sponsors listed in this trial | ||||
| Second Sight Medical Products | |||||
| National Institutes of Health (NIH) | |||||